Finch Therapeutics Group Inc (FNCH)
2.24
-0.06
(-2.61%)
USD |
NASDAQ |
Apr 30, 16:00
2.35
+0.11
(+4.91%)
After-Hours: 20:00
Finch Therapeutics Group Total Assets (Quarterly): 55.37M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 55.37M |
| September 30, 2023 | 59.49M |
| June 30, 2023 | 66.86M |
| March 31, 2023 | 79.04M |
| December 31, 2022 | 162.94M |
| September 30, 2022 | 187.97M |
| June 30, 2022 | 228.30M |
| Date | Value |
|---|---|
| March 31, 2022 | 204.63M |
| December 31, 2021 | 225.37M |
| September 30, 2021 | 232.98M |
| June 30, 2021 | 250.33M |
| March 31, 2021 | 265.95M |
| December 31, 2020 | 165.34M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
55.37M
Minimum
Dec 2023
265.95M
Maximum
Mar 2021
168.04M
Average
187.97M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 748.96M |
| Vanda Pharmaceuticals Inc | 648.44M |
| Sage Therapeutics Inc | 767.60M |
| BioSig Technologies Inc | 1.798M |
| Palisade Bio Inc | 14.05M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 32.49M |
| Shareholders Equity (Quarterly) | 22.89M |